204 related articles for article (PubMed ID: 22919288)
1. Prognostic assessment in patients with indolent B-cell lymphomas.
Arcaini L; Rattotti S; Gotti M; Luminari S
ScientificWorldJournal; 2012; 2012():107892. PubMed ID: 22919288
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, pathology and treatment of non-follicular indolent lymphomas.
Landgren O; Tilly H
Leuk Lymphoma; 2008; 49 Suppl 1():35-42. PubMed ID: 18821431
[TBL] [Abstract][Full Text] [Related]
3. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in low-grade non-Hodgkin lymphomas.
Federico M; Molica S; Bellei M; Luminari S
Curr Hematol Malig Rep; 2009 Oct; 4(4):202-10. PubMed ID: 20425409
[TBL] [Abstract][Full Text] [Related]
5. Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies.
Smyth E; Cheah CY; Seymour JF
Cancer Treat Rev; 2023 Feb; 113():102510. PubMed ID: 36634434
[TBL] [Abstract][Full Text] [Related]
6. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.
Levine AM; Sadeghi S; Espina B; Tulpule A; Nathwani B
Cancer; 2002 Mar; 94(5):1500-6. PubMed ID: 11920507
[TBL] [Abstract][Full Text] [Related]
8. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
9. Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia.
Swerdlow SH
Am J Clin Pathol; 2004 Dec; 122 Suppl():S98-109. PubMed ID: 15690646
[TBL] [Abstract][Full Text] [Related]
10. The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.
Tracy SI; Larson MC; Feldman AL; Maurer MJ; Novak AJ; Slager SL; Villasboas JC; Allmer C; Habermann TM; Farooq U; Syrbu S; Cerhan JR; Link BK
Am J Hematol; 2019 Jun; 94(6):658-666. PubMed ID: 30916801
[TBL] [Abstract][Full Text] [Related]
11. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
12. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.
Monsálvez V; Montes-Moreno S; Artiga MJ; Rodríguez ME; Sanchez-Espiridion B; Lozano M; Fernández-de-Misa R; Rodríguez-Peralto JL; Piris MA; Ortíz-Romero PL
Mod Pathol; 2013 Feb; 26(2):171-81. PubMed ID: 22936066
[TBL] [Abstract][Full Text] [Related]
14. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
16. Marginal zone-related neoplasms of splenic and nodal origin.
Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
[TBL] [Abstract][Full Text] [Related]
17. Pathology of indolent B-cell neoplasms other than follicular lymphoma.
Sakata S; Tsuyama N; Takeuchi K
J Clin Exp Hematop; 2014; 54(1):11-22. PubMed ID: 24942942
[TBL] [Abstract][Full Text] [Related]
18. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of primary cutaneous lymphomas].
Grange F; Bagot M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
[TBL] [Abstract][Full Text] [Related]
20. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
Munari E; Rinaldi M; Ambrosetti A; Bonifacio M; Bonalumi A; Chilosi M; Zamò A
Virchows Arch; 2012 Dec; 461(6):677-85. PubMed ID: 23064660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]